RT @BjoernEskofier: It was a pleasure to conduct this study on #Huntingtonsdisease! @Mobilise_D @FAU_Germany @FAU_MaD_Lab #digitalhealth h…
RT @Mobilise_D: The expertise of our Mobilisers goes far beyond #MobiliseD patient groups. Ultimately our findings will benefit anyone with…
It was a pleasure to conduct this study on #Huntingtonsdisease! @Mobilise_D @FAU_Germany @FAU_MaD_Lab #digitalhealth
RT @Mobilise_D: The expertise of our Mobilisers goes far beyond #MobiliseD patient groups. Ultimately our findings will benefit anyone with…
The expertise of our Mobilisers goes far beyond #MobiliseD patient groups. Ultimately our findings will benefit anyone with mobility problems. Read more about gait variability as digital biomarkers of #Huntington's Disease severity: https://t.co/c5UrKfr0L3
Gait variability as digital biomarker of disease severity in Huntington's disease. https://t.co/lBqVxhDEdG
RT @ingentium_hd: Gait variability as digital #biomarkers of disease severity in #HuntingtonsDisease #HD. https://t.co/SCGfJVoXeg
Gait variability as digital #biomarkers of disease severity in #HuntingtonsDisease #HD. https://t.co/SCGfJVoXeg